AFL
57
-5
NTRS
35
5
HP
33
4
YUM
56
2
EA
70
3
PWR
74
3
GPC
56
2
FRT
58
-5
V
60
2
EMR
39
2
PNR
63
3
HPQ
67
4
UNP
52
2
RIG
44
3
CME
50
5
REGN
71
6
RHI
34
4
DE
39
3
NEE
62
2
FCX
57
5
AFL
57
-5
NTRS
35
5
HP
33
4
YUM
56
2
EA
70
3
PWR
74
3
GPC
56
2
FRT
58
-5
V
60
2
EMR
39
2
PNR
63
3
HPQ
67
4
UNP
52
2
RIG
44
3
CME
50
5
REGN
71
6
RHI
34
4
DE
39
3
NEE
62
2
FCX
57
5
Financhill
Back

Harrow Vs. Relmada Therapeutics Industry Stock Comparison

Sell
24

HROW
Harrow

Last Price:
10.38
Seasonality Move:
3.29%
Sell
40

RLMD
Relmada Therapeutics

Last Price:
3.66
Seasonality Move:
-13.88%
Sell
24
Harrow (HROW) is a Sell

Is Harrow a Buy, Sell or Hold?

  • The current Harrow [HROW] share price is $10.38. The Score for HROW is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • HROW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Relmada Therapeutics (RLMD) is a Sell

Is Relmada Therapeutics a Buy, Sell or Hold?

  • The current Relmada Therapeutics [RLMD] share price is $3.68. The Score for RLMD is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RLMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HROW Stock Price Chart

What is Harrow's stock price today?

  • The Harrow share price today is $10.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HROW is experiencing selling pressure, which indicates risk of future bearish movement.

RLMD Stock Price Chart

What is Relmada Therapeutics's stock price today?

  • The Relmada Therapeutics share price today is $3.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing selling pressure, which indicates risk of future bearish movement.

HROW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 40.44 Sell
Chaikin Money Flow: -156501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.43 - 12.91) Sell
Bollinger Bands (100): (9.8 - 11.92) Sell

RLMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 35.7 Sell
Chaikin Money Flow: -61905 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.8 - 4.74) Sell
Bollinger Bands (100): (3.33 - 5.51) Sell

HROW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.38 Sell
20-day SMA: 11.35 Sell
50-day SMA: 11.42 Sell
200-day SMA: 12.83 Sell
8-day EMA: 10.53 Sell
20-day EMA: 11.01 Sell
50-day EMA: 11.24 Sell
200-day EMA: 12.53 Sell

RLMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.71 Sell
20-day SMA: 4.15 Sell
50-day SMA: 4.92 Sell
200-day SMA: 3.71 Sell
8-day EMA: 3.76 Sell
20-day EMA: 4.07 Sell
50-day EMA: 4.45 Sell
200-day EMA: 4.44 Sell

Harrow Earnings Growth & HROW Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.09 per share, an increase this year of $0.19 per share, and an increase next year of $0.88 per share.

Relmada Therapeutics Earnings Growth & RLMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.39 per share.

Harrow Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Relmada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):